This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1999 Jun 5;353(9168):1896-7.

doi: 10.1016/S0140-6736(99)90074-0.

Breast screening in women aged 40-49 years: what next?

Affiliations

PMID: 10371561
DOI: 10.1016/S0140-6736(99)90074-0

Comment

Breast screening in women aged 40-49 years: what next?

K Dickersin. Lancet. 1999.

. 1999 Jun 5;353(9168):1896-7.

doi: 10.1016/S0140-6736(99)90074-0.

Author

Affiliation

¹ Department of Community Health, Brown University, Providence, RI 02912, USA.

PMID: 10371561
DOI: 10.1016/S0140-6736(99)90074-0

No abstract available

PubMed Disclaimer

Comment in

Breast screening in women aged 40-49 years.
van Bekkum DW. van Bekkum DW. Lancet. 1999 Sep 11;354(9182):946; author reply 947. Lancet. 1999. PMID: 10489972 No abstract available.
Breast screening in women aged 40-49 years.
Kopans DB. Kopans DB. Lancet. 1999 Sep 11;354(9182):946; author reply 947. doi: 10.1016/S0140-6736(05)75688-9. Lancet. 1999. PMID: 10489973 No abstract available.
Breast screening in women aged 40-49 years.
Seltzer MH, McDermott JH. Seltzer MH, et al. Lancet. 1999 Sep 11;354(9182):946-7. doi: 10.1016/S0140-6736(05)75689-0. Lancet. 1999. PMID: 10489974 No abstract available.

Comment on

14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening.
Alexander FE, Anderson TJ, Brown HK, Forrest AP, Hepburn W, Kirkpatrick AE, Muir BB, Prescott RJ, Smith A. Alexander FE, et al. Lancet. 1999 Jun 5;353(9168):1903-8. doi: 10.1016/s0140-6736(98)07413-3. Lancet. 1999. PMID: 10371567 Clinical Trial.
16-year mortality from breast cancer in the UK Trial of Early Detection of Breast Cancer.
[No authors listed] [No authors listed] Lancet. 1999 Jun 5;353(9168):1909-14. Lancet. 1999. PMID: 10371568 Clinical Trial.

Similar articles

Clinical epidemiology and radiology: the need to bridge the gap. Breast screening: a case study.
Zylak CJ. Zylak CJ. Radiology. 1992 Sep;184(3):607-11. doi: 10.1148/radiology.184.3.1509040. Radiology. 1992. PMID: 1509040 No abstract available.
Should women 40 to 49 years of age be offered mammographic screening?
Trop I, Deck W. Trop I, et al. Can Fam Physician. 2006 Sep;52(9):1050-2. Can Fam Physician. 2006. PMID: 17279208 Free PMC article. No abstract available.
The UK breast-screening programme should start at age 47 years.
Sasieni P, Cuzick J. Sasieni P, et al. Lancet. 2003 Jul 19;362(9379):246-7. doi: 10.1016/S0140-6736(03)13922-0. Lancet. 2003. PMID: 12885493 No abstract available.
Screening mammography in women 40 to 49 years of age.
Lisby MD. Lisby MD. Am Fam Physician. 2004 Nov 1;70(9):1750-2. Am Fam Physician. 2004. PMID: 15554494 Review. No abstract available.
[Screening for breast cancer: the time of decision].
Gordenne W. Gordenne W. J Belge Radiol. 1998 Apr;81(2):92-5. J Belge Radiol. 1998. PMID: 9640877 Review. French.

See all similar articles

Cited by

The pathology of familial breast cancer: Clinical and genetic counselling implications of breast cancer pathology.
Lalloo F, Evans DG. Lalloo F, et al. Breast Cancer Res. 1999;1(1):48-51. doi: 10.1186/bcr13. Epub 1999 Oct 27. Breast Cancer Res. 1999. PMID: 11250683 Free PMC article. Review.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information